Literature DB >> 27423863

Biology, Chemistry, and Pharmacology of Sirtuins.

A Bedalov1, S Chowdhury1, J A Simon2.   

Abstract

Sirtuins are a family of protein deacylases related by amino acid sequence and cellular function to the yeast Saccharomyces cerevisiae protein Sir2 (Silent Information Regulator-2), the first of this class of enzymes to be identified and studied in detail. Based on its initially discovered activity, Sir2 was classified as a histone deacetylase that removes acetyl groups from histones H3 and H4. The acetylation/deacetylation of these particular substrates leads to changes in transcriptional silencing at specific loci in the yeast genome, hence its name. Sirtuins, however, have been shown to regulate a wide variety of cellular processes beyond transcriptional repression in varied subcellular compartments and in different cell types. Mechanistically distinct from Zn(2+)-dependent deacylases, sirtuins use nicotinamide adenine dinucleotide as a cofactor in the removal of acetyl and other acyl groups linking metabolic status and posttranslational modification. Sirtuins' unique position has made them attractive targets for small-molecule drug development. In this chapter, we describe the biological roles, therapeutic areas in which sirtuins may play a role and development of small-molecule inhibitors of sirtuins employing phenotypic screening technologies ranging from assays in yeast, as well as biochemical screens to yield lead drug development candidates targeting a broad spectrum of human diseases.
© 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acetylation; Aging; Cancer; Deacetylase; Epigenetic; Inhibitor; Metabolism; Mitochondria; Sirtuin; Transcription

Mesh:

Substances:

Year:  2016        PMID: 27423863     DOI: 10.1016/bs.mie.2016.03.011

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  8 in total

1.  Expression profile of SIRT2 in human melanoma and implications for sirtuin-based chemotherapy.

Authors:  Melissa Jean Wilking-Busch; Mary Ann Ndiaye; Wei Huang; Nihal Ahmad
Journal:  Cell Cycle       Date:  2017-02-06       Impact factor: 4.534

2.  Accurate Quantification of Site-specific Acetylation Stoichiometry Reveals the Impact of Sirtuin Deacetylase CobB on the E. coli Acetylome.

Authors:  Brian Tate Weinert; Shankha Satpathy; Bogi Karbech Hansen; David Lyon; Lars Juhl Jensen; Chunaram Choudhary
Journal:  Mol Cell Proteomics       Date:  2017-03-02       Impact factor: 5.911

Review 3.  Diversion of Acetyl CoA to 3-Methylglutaconic Acid Caused by Discrete Inborn Errors of Metabolism.

Authors:  Dylan E Jones; Elizabeth A Jennings; Robert O Ryan
Journal:  Metabolites       Date:  2022-04-21

Review 4.  Sirtuins and nonalcoholic fatty liver disease.

Authors:  Fatiha Nassir; Jamal A Ibdah
Journal:  World J Gastroenterol       Date:  2016-12-14       Impact factor: 5.742

5.  Development of Second Generation Activity-Based Chemical Probes for Sirtuins.

Authors:  Alyson M Curry; Elizabeth Barton; Wenjia Kang; Daniel V Mongeluzi; Yana Cen
Journal:  Molecules       Date:  2020-12-22       Impact factor: 4.411

Review 6.  Sirtuins and Autophagy in Age-Associated Neurodegenerative Diseases: Lessons from the C. elegans Model.

Authors:  Anam Naseer; Snober Shabnam Mir; Krisztina Takacs-Vellai; Aamir Nazir
Journal:  Int J Mol Sci       Date:  2021-11-12       Impact factor: 5.923

7.  Structure-based design, synthesis, and biological evaluation of novel piperine-resveratrol hybrids as antiproliferative agents targeting SIRT-2.

Authors:  Ahmed H Tantawy; Xiang-Gao Meng; Adel A Marzouk; Ali Fouad; Ahmed H Abdelazeem; Bahaa G M Youssif; Hong Jiang; Man-Qun Wang
Journal:  RSC Adv       Date:  2021-07-27       Impact factor: 4.036

8.  Quercetin Improves Glucose and Lipid Metabolism of Diabetic Rats: Involvement of Akt Signaling and SIRT1.

Authors:  Jing Peng; Qingde Li; Keye Li; Li Zhu; Xiaoding Lin; Xiaohong Lin; Qianhui Shen; Guoping Li; Xi Xie
Journal:  J Diabetes Res       Date:  2017-12-12       Impact factor: 4.011

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.